Literature DB >> 12887271

Regulation of ovarian function by the TGF-beta superfamily and follistatin.

Shyr-Yeu Lin1, John R Morrison, David J Phillips, David M de Kretser.   

Abstract

The role of follistatin as an activin-binding protein has dominated the study of this molecule for the last 10 years. However, there is emerging evidence that follistatin has a role in modulating the biology of other members of the transforming growth factor beta (TGF-beta) superfamily. This review summarizes the current concepts encompassing follistatin biochemistry as well as molecules with which it is functionally associated. Moreover, the importance of the two follistatin isoforms (follistatin-288 and follistatin-315) is discussed with particular emphasis on the regulation of the ovary. In addition to activin, this review discusses the functions of other members of the TGF-beta superfamily, for example growth differentiation factor 9 (GDF-9), bone morphogenetic protein 15 (BMP-15), BMP-6, BMP-4 and BMP-7, in the ovary, and the potential interactions between follistatin and these growth factors. The complex network of TGF-beta superfamily growth factor members involved in the modulation of ovarian function and the interactions of follistatin with these proteins is highlighted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887271     DOI: 10.1530/rep.0.1260133

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  36 in total

1.  The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatin.

Authors:  Anna Gajos-Michniewicz; Elzbieta Pawlowska; Tomasz Ochedalski; Agnieszka Piastowska-Ciesielska
Journal:  J Bone Miner Metab       Date:  2012-02-07       Impact factor: 2.626

2.  Molecular cloning and characterization of follistatin in the gilthead sea bream, Sparus aurata.

Authors:  Bruria Funkenstein; Yanai Rebhan; Tal Skopal
Journal:  Mol Biol Rep       Date:  2008-01-01       Impact factor: 2.316

3.  KDM7 is a dual demethylase for histone H3 Lys 9 and Lys 27 and functions in brain development.

Authors:  Yu-ichi Tsukada; Tohru Ishitani; Keiichi I Nakayama
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

4.  Alteration in follistatin gene expression detected in prenatally androgenized rats.

Authors:  Marziyeh Salehi Jahromi; Fahimeh Ramezani Tehrani; Jennifer W Hill; Mahsa Noroozzadeh; Maryam Zarkesh; Asghar Ghasemi; Azita Zadeh-Vakili
Journal:  Gynecol Endocrinol       Date:  2017-02-26       Impact factor: 2.260

5.  Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.

Authors:  Jerry R Mendell; Zarife Sahenk; Samiah Al-Zaidy; Louise R Rodino-Klapac; Linda P Lowes; Lindsay N Alfano; Katherine Berry; Natalie Miller; Mehmet Yalvac; Igor Dvorchik; Melissa Moore-Clingenpeel; Kevin M Flanigan; Kathleen Church; Kim Shontz; Choumpree Curry; Sarah Lewis; Markus McColly; Mark J Hogan; Brian K Kaspar
Journal:  Mol Ther       Date:  2017-03-06       Impact factor: 11.454

6.  Reply to Letter to the Editor.

Authors:  Jerry R Mendell
Journal:  Mol Ther       Date:  2017-09-08       Impact factor: 11.454

7.  Short-term energy deprivation alters activin a and follistatin but not inhibin B levels of lean healthy women in a leptin-independent manner.

Authors:  Vasiliki A Moragianni; Konstantinos N Aronis; John P Chamberland; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

Review 8.  Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure.

Authors:  Nader Zamani; Chester W Brown
Journal:  Endocr Rev       Date:  2010-12-20       Impact factor: 19.871

9.  The structure of FSTL3.activin A complex. Differential binding of N-terminal domains influences follistatin-type antagonist specificity.

Authors:  Robin Stamler; Henry T Keutmann; Yisrael Sidis; Chandramohan Kattamuri; Alan Schneyer; Thomas B Thompson
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

10.  Transforming growth factor beta (TGFbeta1, TGFbeta2 and TGFbeta3) null-mutant phenotypes in embryonic gonadal development.

Authors:  Mushtaq A Memon; Matthew D Anway; Trevor R Covert; Mehmet Uzumcu; Michael K Skinner
Journal:  Mol Cell Endocrinol       Date:  2008-08-26       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.